Arthritis

  1. Home
  2. Health
  3. Arthritis

Ridaura - Auranofin - Dosage - Side Effects - Interactions - Warnings

Ridaura (auranofin) drug information, dosage, side effects, drug interactions, and warnings. Ridaura, generic drug name auranofin capsules, also known as oral gold, is a disease-modifying anti-rheumatic drug used in the treatment of arthritis. Ridaura helps reduce inflammation and slow disease progression.
Gold Injections - Oral Gold - Is Gold Commonly Or Rarely Used To Treat Rheumatoid Arthritis?
Gold shots were used years ago as a standard treatment for rheumatoid arthritis. Gold is rarely used now to treat rheumatoid arthritis.
Drugs A-Z - Ridaura / Auranofin Capsules
Patient education for Ridaura / auranofin capsules. Ridaura is a gold compound that reduces inflammation and swelling due to arthritis. Gold may affect this system and slow disease progression. Auranofin helps to treat the early stages of adult or juvenile rheumatoid arthritis.
The Facts Of DMARDs
Learn about disease-modifying anti-rheumatic drugs such as methotrexate and gold.
ACR Fact Sheet: Gold Preparations (Ridaura, Myochrysine, Solganol)
Several forms of gold are available. When rheumatologists talk about gold they are usually referring to the injectable forms of gold salts: gold sodium thiomalate (Myochrysine) and aurothioglucose (Solganal). There is also an oral tablet that contains gold, auranofin (Ridaura); however, this preparation is distinct from the injectable forms, and is much less effective, from ACR.
Drug Profile: Gold Compounds (Auranofin, Ridaura)
Drug profile and essential information on gold compounds (Auranofin, Ridaura), from UMM.

Explore Arthritis

About.com Special Features

Do I Have Allergies?

Are your symptoms merely irritating, or could they be a sign of allergies? More >

Preventing Headaches

The best way to treat a headache is to prevent it. Learn how. More >

Arthritis

  1. Home
  2. Health
  3. Arthritis
  4. Arthritis Medications
  5. A - Z: DMARDs
  6. Auranofin (Oral Gold)

©2009 About.com, a part of The New York Times Company.

All rights reserved.